Target intelligence / Profile preview

2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS•+)

Target
ABTS•+
Molecular classification
Chemical reagent, Free radical, Chromogenic substrate
01

Overview

The ABTS radical cation (ABTS•+) is a stable free radical primarily used as a chromogenic substrate in biochemical assays to determine the antioxidant capacity of various substances (Re et al., 1999). It is generated through the oxidation of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) by agents such as potassium persulfate or manganese dioxide (Sigma-Aldrich). In the presence of hydrogen-donating or electron-donating antioxidants, the blue-green radical is reduced to its colorless neutral form, a change that is monitored spectrophotometrically at 734 nm (PubChem CID 5364430). While it is a standard tool in the pharmaceutical industry for screening the radical-scavenging potential of new drug candidates, it is not a physiological target, receptor, or enzyme within the human body. Therefore, it does not have a direct role in disease pathogenesis or therapeutic mechanisms in vivo.

Other names
ABTS radicalABTS radical cation2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate) radicalABTS+
02

Mechanism of action

The ABTS radical cation is reduced by antioxidant compounds through electron transfer or hydrogen atom transfer, leading to the decolorization of the solution which is measured spectrophotometrically (Re et al., 1999).

03

Biological functions

In vitro antioxidant capacity measurement
04

Safety considerations

Not for therapeutic useLaboratory research use onlyPotential skin and eye irritant (Sigma-Aldrich)
05

Interacting drugs

Ascorbic acid

4 more in the full profile.

Beyond the preview

Go deeper on 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS•+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS•+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call